亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北恒綠源生物化工有限公司  

L-肌肽,谷胱甘肽,硫糖鋁,酚酞,黃酚酞,二羥丙茶堿,氨甲環酸,止血環酸,CLT酸

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:高婕
  • 電話:027-88188016
  • 郵件:hbhlykj@126.com
  • 傳真:027-88188026
  • QQ:1764683941
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 禁發 鹽酸苯海拉明
禁發 鹽酸苯海拉明
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
品牌 鹽酸苯海拉明
型號 鹽酸苯海拉明
規格 鹽酸苯海拉明
過期 長期有效
更新 2015-03-03 09:53
 
詳細信息
 禁發 鹽酸苯海拉明禁發 鹽酸苯海拉明 
中文別名: 二甲氨基乙醇二苯甲醚出現被限制詞語; 苯海拉明出現被限制詞語  
英文名稱: Diphenhydramine hydrochloride 
英文別名: Benzhydramine hydrochloride; Dimedrolum; Benzhydramine; Diphenhydramine HCl; Diphenhydramine hydrochlorids; N-(2-Diphenylmethoxyethyl)-N,N-dimethylamine hydrochloride; 2-(diphenylmethoxy)-N,N-dimethylethanamine; 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride (1:1) 
CAS號: 147-24-0;8052-21-9 
EINECS號: 205-687-2 
分子式: C17H21NO·HCl 
分子量: 291.82  
InChI: InChI=1/C17H21NO.2ClH/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;;/h3-12,17H,13-14H2,1-2H3;2*1H  
分子結構:   
熔點: 168-172℃  
水溶性: 1000 g/L  
©2025 湖北恒綠源生物化工有限公司 版權所有   技術支持:化工網   訪問量:7859  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |